$Sangamo Therapeutics (SGMO.US)$ Late on posting this but he...
Late on posting this but here it is. I'm not trading again today, not focused on it anyways, maybe some quick in and outs.
Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
Positive
Secured $20 million upfront license fee from Astellas
Potential to earn up to $1.3 billion in additional fees and milestone payments
Will receive tiered mid-to-high single-digit royalties on potential net sales
No development or commercialization costs for Sangamo
Negative
Revenue generation dependent on Astellas' success in development and commercialization
Milestone payments are not guaranteed and subject to development achievements
Secured $20 million upfront license fee from Astellas
Potential to earn up to $1.3 billion in additional fees and milestone payments
Will receive tiered mid-to-high single-digit royalties on potential net sales
No development or commercialization costs for Sangamo
Negative
Revenue generation dependent on Astellas' success in development and commercialization
Milestone payments are not guaranteed and subject to development achievements
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Amp : There is nothing negative about the deal. They have cash and opportunities to earn more that they didn’t have before, it’s all positive.
Andy-Lai :
This_Guy OP Amp : The positive far outweighs the negative but as you can see in the post there are some potential negative aspects to watch for long term.